Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance

Diabetologia

Volumn 40, Issue 5, 1997, Pages 541-549

  Turpeinen, A K ^a,b   Kuikka, J T ^a   Vanninen, E ^a   Uusitupa, M I J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

diabetic heart muscle disease; fatty acids; heptadecanoic acid; impaired glucose tolerance; myocardial metabolism; SPET

Indexed keywords

17 IODOHEPTADECANOIC ACID I 123;

ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FATTY ACID METABOLISM; GLUCOSE INTOLERANCE; HEART MUSCLE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANALYSIS OF VARIANCE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; GLUCAGON; GLUCOSE INTOLERANCE; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIUM; REFERENCE VALUES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR FUNCTION, LEFT;

EID: 0030951483     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050713     Document Type: Article

References (41)

1. Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham Study. JAMA 241: 2035-2038
2. Pyörälä K, Laakso M, Uusitupa M (1987) Diabetes and atherosclerosis: an epidemiologic view. Diab Met Rev 3: 463-524
3. Galderisi M, Anderson KM, Wilson PWF, Levy D (1991) Echocardiographic evidence for the existence of distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68: 85-89
4. Fein FS, Sonnenblick EH (1994) Diabetic cardiomyopathy. Cardiovasc Drugs Ther 8: 65-73
5. Uusitupa MIJ, Mustonen JN, Airaksinen KEJ (1990) Diabetic heart muscle disease. Ann Med 22: 377-386
6. Fields LE, Daugherty A, Bergmann SR (1986) Effect of fatty acid on performance and lipid content of hearts from diabetic rabbits. Am J Physiol 250:H1079-H1085
7. Rodrigues B, McNeill JH (1992) The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26: 913-922
8. Opie LH (1991) Fuels: carbohydrates and lipids. In: Opie LH (ed) The heart: physiology and metabolism. Raven Press, New York, pp. 208-246
9. Wall SR, Lopaschuk GD (1989) Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochem Biophys Acta 1006: 97-103
10. Christe ME, Rodgers RL (1995) Cardiac glucose and fatty acid oxidation in the streptozotocin-induced diabetic spontaneously hypertensive rat. Hypertension 25: 235-241
11. Avogaro A, Nosadini R, Doria A et al. (1990) Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 258:E606-E618
12. Frayn KN (1993) Insulin resistance and lipid metabolism. Curr Opin Lipidol 4: 197-204
13. Kuikka JT, Mustonen JN, Uusitupa MIJ et al. (1991) Demonstration of disturbed free fatty acid metabolism of myocardium in patients with non-insulin dependent diabetes mellitus as measured with iodine-123-heptadecanoic acid. Eur J Nucl Med 18: 475-481
14. Voipio-Pulkki L, Nuutila P, Knuuti MJ et al. (1993) Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined with positron emission tomography. J Nucl Med 34: 2064-2067
15. Ohtake T, Yokoyama I, Watanabe T et al. (1995) Myocardial glucose metabolism in non-insulin-dependent diabetes mellitus patients evaluated by FDG-PET. J Nucl Med 36: 456-463
16. Nuutila P, Knuuti J, Ruotsalainen U et al. (1993) Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes. Am J Physiol 264:E756-E762
17. World Health Organization (1985) Diabetes mellitus: report of a WHO study group. Geneva. World Health Organization (Tech. Rep. Sen, no. 727)
18. Bergman RN (1989) Toward physiological understanding of glucose tolerance. Diabetes 38: 1512-1527
19. Penttilä IM, Voutilainen E, Laitinen O, Juutilainen P (1981) Comparison of different analytical and precipitation methods for the direct estimation of high-density lipoprotein cholesterol. Scand J Clin Lab Invest 41: 353-360
20. Welch S, Gebhart SSP, Bergman RN, Phillips LN (1990) Minimal model analysis of intravenous test-derived insulin sensitivity in diabetic subjects. J Clin Endocr Metab 71: 1508-1518
21. Pacini G, Bergman RN (1986) A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23: 112-122
22. Schelbert HR (1986) Features of positron emission tomography as a probe for myocardial chemistry. Eur J Nucl Med 12:s2-s10
23. DeGrado TR, Holden JE, Ng CK, Raffel DM, Gatley SJ (1989) Quantative analysis of myocardial kinetics of 15-p-[Iodine-125]Iodophenylpentadecanoic acid. J Nucl Med 30: 1211-1218
24. Kootsey JM (1989) Introduction to computer simulation. National Simulation Resource, Duke University, Durham, NC (with support from NIH grant RR01 693)
25. Bergmann SR, Weinheimer CJ, Markham J, Herrero P (1996) Quantitation of myocardial fatty acid kinetics using PET. J Nucl Med 37: 1723-1730
26. Huikuri HV, Korhonen UR, Airaksinen KEJ, Ikäheimo MJ, Heikkilä J, Takkunen JT (1988) Comparison of dipyridamole-handgrip test and bicycle exercise test for thallium tomographic imaging. Am J Cardiol 61: 264-268
27. Vanninen E, Mustonen J, Vainio P, Länsimies E, Uusitupa M (1992) Left ventricular function and dimensions in newly diagnosed non-insulin-dependent diabetes mellitus. Am J Cardiol 70: 371-378
28. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1979) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement. Circulation 58: 1072-1083
29. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618
30. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607
31. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet I:785-789
32. Nuutila P, Koivisto VA, Knuuti J et al. (1992) The glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89: 1767-1744
33. Luthy P, Chatelain P, Papageorgiou I, Schubiger A, Lerch RA (1988) Assessment of myocardial metabolism with iodine-123 heptadecanoic acid: effect of decreased fatty acid oxidation on deiodination. J Nucl Med 29: 1088-1095
34. Sloof GW, Visser FC, van Eenige MJ et al. (1993) Comparison of uptake, oxidation and lipid distribution of 17-iodoheptadecanoic acid, 15-(p-iodophenyl)pentadecanoic acid and 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid in normal canine myocardium. J Nucl Med 34: 649-657
35. Kelley DE, Simoneau J-A (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Inv 94: 2349-2356
36. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89: 9252-9256
37. Maggs DG, Jacob R, Rife F et al. (1995) Interstitial fluid concentrations of glycerol, glucose and amino acids in human quadriceps muscle and adipose tissue. J Clin Invest 96: 370-377
38. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipids. Diabetes 40: 280-289
39. Allardt MF, Schönekess BO, Henning SL, English DR, Lopaschuk GD (1994) Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 267:H742-H750
40. Uusitupa M, Siitonen O, Pyörälä K et al. (1987) Relationship of blood pressure and left ventricular mass to serum insulin levels in newly diagnosed non-insulin-dependent (type 2) diabetic patients and in non-diabetic subjects. Diab Res 4: 19-25
41. Sasson Z, Rasooly Y, Bhesania T, Rasooly I (1993) Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 88 [part 1]:1431-1436